Researchers are studying high dose vitamin C as part of treatment for several cancers, including pancreatic cancer. These high doses of vitamin C (pharmacologic ascorbate) are not taken orally (by mouth), but in IVs (taken intravenously). It is always given alongside chemotherapy.
The intravenous vitamin C doses are 150 to 190 times larger than ordinary vitamin C tablets that are taken orally. This is because orally taken vitamin C cannot reach the blood levels needed to produce a pharmacologic effect.
Some of the results are amazing. For example, persons with pancreatic cancer it doubled survival compared to chemotherapy alone (from 8 months to 16 months) , and those receiving vitamin C used alongside standard chemotherapy had fewer side effects than when using chemotherapy alone. It is still unclear for which cancers the vitamin C treatment works and for which it doesn't.
The only problem is that pharma companies may not be interested because it can not be patented, and can't be developed as a new drug that they can make big profits off of. It's plain old vitamin C - but not as a nutritional supplement, but used as a medical drug (pharmacologic ascorbate).
Click on the link for the full story and dosing details. Excerpts from Medscape: Vitamin C’s Potential Use in Cancer Is Getting a Second Look
When Garry Buettner, PhD, who has been studying the chemistry and biochemistry of vitamin C for at least four decades, was diagnosed with myelodysplastic syndromes (MDS), he applied his research to his own life — reviewing the data and designing a protocol for his treatment. ...continue reading "High Dose Vitamin C As Part of Cancer Treatment?"